On Nov 1, 2021 NovaBay Pharmaceuticals closed a Post-IPO Equity round and raised $15,000,000 from investors, featuring lead investors . About the company: NovaBay Pharmaceuticals […]
Grant – Mustang Bio
On Nov 1, 2021 Mustang Bio closed a Grant round and raised $2,000,000 from National Institutes of Health, featuring lead investors . About the company: […]
Grant – InterveXion Therapeutics
On Nov 1, 2021 InterveXion Therapeutics closed a Grant round and raised $13,800,000 from National Institutes of Health, featuring lead investors National Institutes of Health. […]
Post-IPO Equity – Valneva
On Nov 1, 2021 Valneva closed a Post-IPO Equity round and raised €88,000,000 from investors, featuring lead investors . About the company: Valneva is located […]
Seed Round – Swiftsure Innovations
On Nov 1, 2021 Swiftsure Innovations closed a Seed round and raised $1,050,000 from Killick Capital, Pelorus Venture Capital, Pluto Investments, Sandpiper Ventures, Threshold Impact, […]
Non Equity Assistance – Swiftsure Innovations
On Nov 1, 2021 Swiftsure Innovations closed a Non-equity Assistance round and raised $149,500 from Newfoundland and Labrador Department of Innovation, Energy and Technology, featuring […]
Post-IPO Equity – NovaBay Pharmaceuticals
On Nov 1, 2021 NovaBay Pharmaceuticals closed a Post-IPO Equity round and raised $15,000,000 from investors, featuring lead investors . About the company: NovaBay Pharmaceuticals […]
Seed Round – Ombre
On Nov 1, 2021 Ombre closed a Seed round and raised $3,000,000 from Joyance Partners, PivotNorth Capital, Shanda Group, TMV, Unilever Ventures, Unpopular Ventures, featuring […]
Venture Round – Vensica Medical
On Nov 1, 2021 Vensica Medical closed a Venture – Series Unknown round and raised $16,000,000 from Agriline, Israel Biotech Fund, Laborie Medical Technologies, Lewis […]
Series B – Hopstem
On Oct 31, 2021 Hopstem closed a Series B round and raised $40,000,000 from BioVenture, Lilly Asia Ventures, featuring lead investors . About the company: […]